Saptalis launches cyclosporine ophthalmic emulsion 0.05% for dry eye

Saptalis Pharmaceuticals launched generic cyclosporine ophthalmic emulsion 0.05% for the treatment of dry eye disease, according to press release.According to the release, the eye drop, a generic of Restasis (cyclosporine ophthalmic emulsion 0.05%, AbbVie), will be available in 30- and 60-count single-use vials. It is indicated for increasing tear production, providing “a convenient option